# LISDEXAMFETAMINE DIMESYLATE
> **ANDA219258** · Abbreviated New Drug Application (Generic) · Sponsor: GRANULES · Approved 2024-12-16
## Drug
- **FDA Application Number:** ANDA219258
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LISDEXAMFETAMINE DIMESYLATE
- **Generic name:** LISDEXAMFETAMINE DIMESYLATE
- **Active ingredients:** LISDEXAMFETAMINE DIMESYLATE
- **Dosage form:** TABLET, CHEWABLE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** GRANULES
- **Manufacturer:** Granules Pharmaceuticals Inc.
- **First approval:** 2024-12-16
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219258)
---
*AI Analytics · CC0 1.0*